Vident Advisory’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,083
Closed -$360K 1608
2025
Q1
$360K Buy
+3,083
New +$360K 0.01% 1195